CTI BioPharma Statistics
Total Valuation
PAPL has a market cap or net worth of $4.33 million. The enterprise value is $4.67 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PAPL has 1.00 million shares outstanding. The number of shares has increased by 33.70% in one year.
| Current Share Class | 1.00M |
| Shares Outstanding | 1.00M |
| Shares Change (YoY) | +33.70% |
| Shares Change (QoQ) | +40.86% |
| Owned by Insiders (%) | 27.38% |
| Owned by Institutions (%) | 0.93% |
| Float | 729,571 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.67 |
| Forward PS | 8.39 |
| PB Ratio | 5.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58, with a Debt / Equity ratio of 1.75.
| Current Ratio | 0.58 |
| Quick Ratio | 0.54 |
| Debt / Equity | 1.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.46 |
Financial Efficiency
Return on equity (ROE) is -244.79% and return on invested capital (ROIC) is -68.79%.
| Return on Equity (ROE) | -244.79% |
| Return on Assets (ROA) | -41.60% |
| Return on Invested Capital (ROIC) | -68.79% |
| Return on Capital Employed (ROCE) | -131.04% |
| Revenue Per Employee | $54,127 |
| Profits Per Employee | -$64,315 |
| Employee Count | 55 |
| Asset Turnover | 0.66 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +315.62% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +315.62% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 64.04 |
| Average Volume (20 Days) | 5,958,631 |
Short Selling Information
The latest short interest is 4,323, so 0.43% of the outstanding shares have been sold short.
| Short Interest | 4,323 |
| Short Previous Month | 2,110 |
| Short % of Shares Out | 0.43% |
| Short % of Float | 0.59% |
| Short Ratio (days to cover) | 1.09 |
Income Statement
In the last 12 months, PAPL had revenue of $2.98 million and -$3.54 million in losses. Loss per share was -$7.60.
| Revenue | 2.98M |
| Gross Profit | 2.98M |
| Operating Income | -3.00M |
| Pretax Income | -2.95M |
| Net Income | -3.54M |
| EBITDA | -3.28M |
| EBIT | -3.00M |
| Loss Per Share | -$7.60 |
Full Income StatementBalance Sheet
The company has $1.13 million in cash and $1.47 million in debt, giving a net cash position of -$337,653 or -$0.34 per share.
| Cash & Cash Equivalents | 1.13M |
| Total Debt | 1.47M |
| Net Cash | -337,653 |
| Net Cash Per Share | -$0.34 |
| Equity (Book Value) | 842,565 |
| Book Value Per Share | 0.84 |
| Working Capital | -1.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$703,849 and capital expenditures -$29, giving a free cash flow of -$703,878.
| Operating Cash Flow | -703,849 |
| Capital Expenditures | -29 |
| Free Cash Flow | -703,878 |
| FCF Per Share | -$0.70 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -100.74% and -118.82%.
| Gross Margin | 100.00% |
| Operating Margin | -100.74% |
| Pretax Margin | -118.82% |
| Profit Margin | -118.82% |
| EBITDA Margin | -110.25% |
| EBIT Margin | -100.74% |
| FCF Margin | n/a |
Dividends & Yields
PAPL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.70% |
| Shareholder Yield | -33.70% |
| Earnings Yield | -81.70% |
| FCF Yield | -16.26% |
Analyst Forecast
The average price target for PAPL is $5.00, which is 16.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 16.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 16, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jul 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
PAPL has an Altman Z-Score of -4.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.44 |
| Piotroski F-Score | 2 |
